Disease Site
Blood/Bone Marrow
You have full text access to this OnlineOpen article
Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease : Potential therapeutic significance (pages 1–5)Katharina Clodi, Zahra Asgari, Mamoun Younes, J. Lynn Palmer, Fernando Cabanillas, Antonino Carbone, Michael Andreeff and Anas Younes
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10164
The malignant Hodgkin and Reed–Sternberg cells (H/RS) of Hodgkin disease express CD40 receptor that can transduce survival signals. In this report, the authors identify benign infiltrating and circulating B cells as a potential source for CD40 ligand, raising the possibility that B cells may contribute to the survival of H/RS cells in vivo.
You have full text access to this OnlineOpen article
Lymphomas of the breast : Primary and secondary involvement (pages 6–13)Susan M. Domchek, Jonathan L. Hecht, Mark D. Fleming, Geraldine S. Pinkus and George P. Canellos
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10163
Eighty-one patients with lymphomatous involvement of the breast were evaluated retrospectively, and clinical data were obtained; 44% of patients had primary lymphoma of the breast, and the other patients had breast involvement of disseminated disease at the time of initial diagnosis (29%) or had a recurrence of preexisting lymphoma to the breast (27%). Screening mammography has not altered substantially the detection of breast lymphoma.
You have full text access to this OnlineOpen article
Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome (pages 14–17)Raymond Lai, Elihu Estey, Yu Shen, Simona Despa, Hagop Kantarjian, Miloslav Beran, Taghi Maushouri, Robert C. Quackenbuch, Micheal Keating and Maher Albitar
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10200
This study showed that high levels of plasma endostatin correlated with poor clinical outcomes in patients with acute myeloid leukemia/myelodysplastic syndrome.
You have full text access to this OnlineOpen article
Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies (pages 18–24)Sang-Kyun Sohn, Jin-Tae Jung, Dong-Hwan Kim, Nan-Young Lee, Kwang-Woon Seo, Yee-Soo Chae, Soung-Won Park, Jong-Gwang Kim, Jang-Soo Suh and Kyu-Bo Lee
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10165
Allogeneic peripheral blood stem cell transplantation with prophylactic growth factor-primed donor lymphocyte infusion may be a potentially curative strategy for the treatment of patients with hematologic malignancies who have a high risk of recurrence.
Breast Disease
You have full text access to this OnlineOpen article
Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma (pages 25–36)Lyndsay Harris, Gerald Batist, Robert Belt, Douglas Rovira, Rudolph Navari, Nozar Azarnia, Lauri Welles and Eric Winer, TLC D-99 Study Group
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10201
The authors compared the efficacy and toxicity of the liposome-encapsulated doxorubicin, TLC D-99 and conventional doxorubicin in first-line treatment of metastatic breast carcinoma. They found that single-agent TLC D-99 produces less cardiotoxicity than doxorubicin, while providing comparable antitumor activity.
You have full text access to this OnlineOpen article
The pattern of breast cancer screening utilization and its consequences (pages 37–43)James Michaelson, Sameer Satija, Richard Moore, Griffin Weber, Elkan Halpern, Andrew Garland, Dhruv Puri and Daniel B. Kopans
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10154
Understanding why women fail to use breast cancer screening as recommended and finding ways to encourage prompt annual screening from the age of 40 years may lead to considerable reductions in death from breast carcinoma, and such efforts should have a high priority.
Endocrine Disorders
You have full text access to this OnlineOpen article
Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome : Influence of the stage on the clinical course (pages 44–50)S. Leboulleux, J. P. Travagli, B. Caillou, A. Laplanche, J. M. Bidart, M. Schlumberger and E. Baudin
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10205
In multiple endocrine neoplasia type 2B (MEN 2B) patients, total thyroidectomy together with neck lymph node dissection should be performed as soon as the diagnosis of the MEN 2B syndrome is made, preferably within the first 6 months of life. The authors did not demonstrate a more aggressive phenotype of medullary thyroid carcinoma (MTC) occurring in MEN 2B syndrome, compared with other MTCs.
You have full text access to this OnlineOpen article
Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma : Effectiveness of dacarbazine (pages 51–61)Rhona Stein, Susan Chen, Linda Reed, Heidi Richel and David M. Goldenberg
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10157
Combined modality therapy using radioimmunotherapy and chemotherapy with dacarbazine (DTIC) or a two- or four-drug combination including DTIC augments the antitumor efficacy of either modality alone for medullary thyroid carcinoma, without a significant increase in toxicity.
Gastrointestinal Tract
You have full text access to this OnlineOpen article
Intraductal papillary-mucinous neoplasms of the pancreas : An analysis of in situ and invasive carcinomas in 28 patients (pages 62–77)N. Volkan Adsay, Kevin C. Conlon, Sui Y. Zee, Murray F. Brennan and David S. Klimstra
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10203
Both in situ and invasive carcinoma in pancreatic intraductal papillary-mucinous neoplasms (IPMNs) may be more common than previously recognized. Colloid (mucinous) carcinomas and tubular carcinomas occur that resemble conventional ductal adenocarcinomas. Although they are less aggressive as a group than ductal adenocarcinomas, IPMNs may pursue a deadly course, even in the absence of identifiable invasive carcinoma. Conversely, patients with invasive tubular carcinomas arising from IPMNs may have a more favorable clinical course than patients with ductal adenocarcinomas without an IPMN component.
You have full text access to this OnlineOpen article
Early gastric carcinoma with signet ring cell histology (pages 78–83)Woo Jin Hyung, Sung Hoon Noh, Jun Ho Lee, Jihun J. Huh, Ki Hyeok Lah, Seung Ho Choi and Jin Sik Min
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10120
A retrospective study of 933 patients who had undergone gastrectomy for early gastric carcinoma revealed that early gastric carcinoma with signet ring cell histology had a lower rate of lymph node metastasis and more favorable prognosis. Early gastric carcinoma with signet ring cell histology could be managed by less invasive surgery.
You have full text access to this OnlineOpen article
Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma–pancreatic carcinoma–prone families : The familial atypical multiple mole melanoma–pancreatic carcinoma syndrome (pages 84–96)Henry T. Lynch, Randall E. Brand, David Hogg, Carolyn A. Deters, Ramon M. Fusaro, Jane F. Lynch, Ling Liu, Joseph Knezetic, Norman J. Lassam, Michael Goggins and Scott Kern
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10159
The familial atypical multiple mole melanoma syndrome shows a strong association with pancreatic carcinoma in context with the CDKN2A germline mutation that may constitute a hereditary cancer syndrome involving these and possibly other forms of cancer.
You have full text access to this OnlineOpen article
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma (pages 97–103)David P. Ryan, Matthew H. Kulke, Charles S. Fuchs, Michael L. Grossbard, Steven R. Grossman, Jeffrey A. Morgan, Craig C. Earle, Ramesh Shivdasani, Haesook Kim, Robert J. Mayer and Jeffrey W. Clark
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10202
This Phase II study of gemcitabine and docetaxel in patients with advanced pancreatic carcinoma demonstrated that this combination is tolerable. A median survival of 8.9 months in this patient population warrants further exploration of this combination in multicenter studies.
Genitourinary Disease
You have full text access to this OnlineOpen article
Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor (pages 104–110)Liang Cheng, Jian Gu, Thomas M. Ulbright, Gregory T. MacLennan, Christopher J. Sweeney, Shaobo Zhang, Katya Sanchez, Michael O. Koch and John N. Eble
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10151
The authors used analysis of X chromosome inactivation to determine the clonal origin of muscle-invasive urothelial carcinoma of the urinary bladder. Some muscle-invasive urothelial carcinomas may arise from independently transformed progenitor urothelial cells, supporting the “field effect” theory for bladder carcinogenesis.
You have full text access to this OnlineOpen article
Active chemotherapy for collecting duct carcinoma of the kidney : A case report and review of the literature (pages 111–116)Matthew I. Milowsky, Alyssa Rosmarin, Satish K. Tickoo, Nicholas Papanicolaou and David M. Nanus
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10204
Collecting or Bellini duct carcinoma (CDC) is a rare variant of kidney carcinoma that is associated with an aggressive course and extremely poor prognosis. CDC accounts for approximately 1–3% of all renal neoplasms and has a tendency to occur in younger, male, and white patients. Immunotherapy does not appear to be effective and to the authors' knowledge there are no standard treatment regimens for CDC. In the current study, the authors report a patient with CDC who achieved a major response to combination chemotherapy with doxorubicin and gemcitabine.
Gynecologic Oncology
You have full text access to this OnlineOpen article
High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix : A randomized trial (pages 117–124)Masato Hareyama, Koh-ichi Sakata, Atushi Oouchi, Hisayasu Nagakura, Mitsuo Shido, Masanori Someya and Kazumitsu Koito
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10207
The pelvic control or actuarial complication rates were comparable between high-dose-rate and low-dose-rate treatment in a prospective randomized clinical trial for the treatment of cervical carcinoma.
You have full text access to this OnlineOpen article
The prognostic value of immunohistochemically detected CD44v3 and CD44v6 expression in patients with surgically staged vulvar carcinoma : A multicenter study (pages 125–130)Lukas A. Hefler, Nicole Concin, David Mincham, Jane Thompson, Nikkie B. Swarte, Marion A. van Eijkeren, Daisy M.D.S. Sie-Go, Ian Hammond, Anthony J. McCartney, Clemens B. Tempfer and Paul Speiser
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10206
In patients with vulvar carcinoma, the adhesion molecule CD44v6 confers prognostic information in addition to that provided by the established clinicopathologic parameters of tumor stage and lymph node status.
You have full text access to this OnlineOpen article
Quality of life and mood in women with gynecologic cancer : A one year prospective study (pages 131–140)Susan K. Lutgendorf, Barrie Anderson, Philip Ullrich, Erica L. Johnsen, Richard E. Buller, Anil K. Sood, Joel I. Sorosky and Justine Ritchie
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10155
Quality of life and mood were prospectively investigated for one year among women with early stage and regionally advanced gynecologic cancers. Over and above disease extent and treatment intensity, patients' ability to find positive meaning, acceptance, and social support was prospectively related to better QOL at one year, whereas disengagement was related to poorer QOL and mood.
You have full text access to this OnlineOpen article
Lack of significant differences in the corrected activity of lysophospholipase D, producer of phospholipid mediator lysophosphatidic acid, in incubated serum from women with and without ovarian tumors (pages 141–151)Akira Tokumura, Kyoko Tominaga, Katsuhiko Yasuda, Hideharu Kanzaki, Kentaro Kogure and Kenji Fukuzawa
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10146
The activity of serum lysophospholipase D, which produces bioactive lysophosphatidic acids in patients with ovarian tumors, was roughly equivalent in healthy women, patients with benign tumors, and patients with ovarian carcinoma. Therefore, the activity of serum lysophospholipase D would not be a good marker for ovarian carcinoma.
Head and Neck Disease
You have full text access to this OnlineOpen article
Serum squamous cell carcinoma antigen is a useful biologic marker in patients with inverted papillomas of the sinonasal tract (pages 152–158)Ryuji Yasumatsu, Torahiko Nakashima, Yuichiro Kuratomi, Naoya Hirakawa, Kaoru Azuma M.S., Kichinobu Tomita, Sule Cataltepe, Gary A. Silverman, Gary L. Clayman and Sohtaro Komiyama
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10144
Serum squamous cell carcinoma (SCC) antigen is transcribed by two nearly identical genes (SCCA1 and SCCA2) and is produced mainly by SCCA1. In the current study, the authors found that the serum SCC antigen level was high in patients with sinonasal inverted papilloma (IP), and that IP overexpressed SCCA1. Serum SCC antigen may have potential to be a useful biologic marker for patients with sinonasal IP.
You have full text access to this OnlineOpen article
The effects of exogenous p53 overexpression on HPV-immortalized and carcinogen transformed oral keratinocytes (pages 159–166)George H. Yoo, James Washington, Jeffrey Oliver, Marie Piechocki, Harold Kim, Jessica Foster-Nora, Terry Y. Shibuya, Deborah R. Wilson and John F. Ensley
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10210
Gene transfer and expression of exogenous p53 by using Ad-p53 demonstrates suppressive effects on human papillomavirus immortalized and carcinogen transformed oral keratinocytes as well as head and neck carcinoma cells. Results suggest that p53 gene transfer may be appropriate for clinical studies in patients at risk for head and neck carcinoma.
Hepatobiliary Tract
You have full text access to this OnlineOpen article
Expression of glial cell line-derived neurotrophic factor correlates with perineural invasion of bile duct carcinoma (pages 167–174)Naoko Iwahashi, Tetsuro Nagasaka, Gaye Tezel, Toshihide Iwashita, Naoya Asai, Yoshiki Murakumo, Kazutoshi Kiuchi, Keita Sakata, Yuji Nimura and Masahide Takahashi
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10169
It has been suggested that the expression of glial cell line-derived neurotrophic factor (GDNF) in patients with bile duct carcinoma plays a role in perineural invasion, which is a prognostic factor, through chemoattraction to its receptors, GDNF receptor α1 and RET receptor tyrosine kinase, which are expressed in peripheral nerve tissues.
You have full text access to this OnlineOpen article
Transforming growth factor-β1 as a useful serologic marker of small hepatocellular carcinoma (pages 175–180)Byung-Cheol Song, Young-Hwa Chung, Jung A. Kim, Won-Beom Choi, Dong Dae Suh, Seung Il Pyo, Jung Woo Shin, Han Chu Lee, Yung Sang Lee and Dong Jin Suh
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10170
Transforming growth factor-β1 may be a useful serologic marker in detecting hepatocellular carcinomas earlier because it shows higher sensitivity than alpha-fetoprotein with the same specificity in the diagnosis of small hepatocellular carcinomas.
Lung Disease
You have full text access to this OnlineOpen article
Therapy choices among older patients with lung carcinoma : An evaluation of two trials of the cancer and leukemia group B (pages 181–187)Caio Max S. Rocha Lima, James E. Herndon II, Michael Kosty, Gerald Clamon and Mark R. Green
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10174
Age should not dictate which septuagenarians should be entered on chemotherapy-based treatment studies among patients with Stage III and IV nonsmall cell lung carcinoma.
You have full text access to this OnlineOpen article
p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma (pages 188–196)Marcel Th. M. van Rens, Erik J. E. Eijken, Johannes R. J. Elbers, Jan-W. J. Lammers, Marcel G. J. Tilanus and Pieter J. Slootweg
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10001
p53 mutation analysis is helpful in distinguishing pulmonary metastasis from second primary lung carcinoma.
Skin and Soft Tissue
You have full text access to this OnlineOpen article
Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas (pages 197–204)Geoffrey A. Porter, Scott B. Cantor, Syed A. Ahmad, Jeffrey T. Lenert, Matthew T. Ballo, Kelly K. Hunt, Barry W. Feig, Shreyaskumar R. Patel, Robert S. Benjamin, Raphael E. Pollock and Peter W. T. Pisters
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10184
In a cohort of 600 patients with primary nonthoracic T2 soft tissue sarcomas, routine chest computed tomography (CT) scanning was most cost-effective in patients with extremity and/or high-grade lesions. Chest CT scanning had a lower yield, was less cost-effective, and did not appear to be indicated routinely for patients with low-grade sarcomas.
Discipline
Pathology
You have full text access to this OnlineOpen article
Use of magnetic enrichment for detection of carcinoma cells in fluid specimens (pages 205–211)Eric Kielhorn, Kevin Schofield and David L. Rimm
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10193
Immunomagnetic epithelial cell enrichment can find tumor cells in pleural and peritoneal fluids that would not be detected by conventional cytologic analysis.
Translational Research
You have full text access to this OnlineOpen article
Detection of genetic alterations in the p53 suppressor gene and the K-ras oncogene among different grades of dysplasia in patients with colorectal adenomas (pages 219–227)Shigetoshi Hosaka, Yuji Aoki, Taiji Akamatsu, Naoshi Nakamura, Noriko Hosaka and Kendo Kiyosawa
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10198
The genetic model for colorectal tumorigenesis is well known, and colorectal adenomas, which have varying degrees of dysplasia, have been considered attractive neoplastic lesions for the analysis of genetic changes in the early stage of colorectal tumorigenesis. Although it is believed that p53 suppressor gene mutations, compared with the K-ras oncogene, occur at a later stage of colorectal tumorigenesis, the distribution of these genetic alterations at an early stage remains poorly characterized. In this study, it was found that the prevalence and frequency of p53 positive immunostaining were significantly greater compared with those of K-ras mutations in both low-grade and high-grade dysplasia, suggesting that the p53 suppressor gene may be associated more closely with the progression of colorectal adenomas compared with the K-ras oncogene.
You have full text access to this OnlineOpen article
Influences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinoma (pages 228–239)Beat M. Künzli, Pascal O. Berberat, Zhaowhen W. Zhu, Marcus Martignoni, Jörg Kleeff, Adrien A. Tempia-Caliera, Minoru Fukuda, Arthur Zimmermann, Helmut Friess and Markus W. Büchler
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10162
Galectin ligands Lamp-1, Lamp-2, and Mac-2-BP that influence tumor progression by altering cell to cell interaction were analyzed in human pancreatic carcinoma. Lamp-1 overexpression was associated with better survival, whereas for Lamp-2 and Mac-2-BP this was not observed.
You have full text access to this OnlineOpen article
Enhanced expression of telomerase activity in thymoma and thymic carcinoma tissues : A clinicopathologic study (pages 240–244)Masazumi Watanabe, Shan-kang Yu, Makoto Sawafuji, Masafumi Kawamura, Hirohisa Horinouchi, Makio Mukai and Koichi Kobayashi
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10194
Telomerase activity in thymoma tissue is higher than in both thymic carcinoma and primary lung adenocarcinoma. Telomerase activity relates to induced immature lymphocytes in thymoma and relates to tumor stage in thymic carcinoma.
Medical Oncology
You have full text access to this OnlineOpen article
Catheter-related infection and thrombosis of the internal jugular vein in hematologic-oncologic patients undergoing chemotherapy : A prospective comparison of silver-coated and uncoated catheters (pages 245–251)Christoph Harter, Hans Jürgen Salwender, Alfons Bach, Gerlinde Egerer, Hartmut Goldschmidt and Anthony D. Ho
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10199
Catheter-related venous thrombosis is one of the most frequent complications of central venous catheters. The objective of this prospective study was to assess whether silver-coated central venous catheters pose an additional risk in the development of catheter-related thrombosis. The authors concluded that the novel silver-coated central venous catheter does not cause a higher rate of central venous thrombosis compared with standard central venous catheters.
Pediatric Oncology
You have full text access to this OnlineOpen article
Undifferentiated sarcoma of the liver in childhood : A curable disease (pages 252–257)Gianni Bisogno, Thorsten Pilz, Giorgio Perilongo, Andrea Ferrari, Dieter Harms, Vito Ninfo, Jorn Treuner and Modesto Carli
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10191
The combined experience of the Italian and German Cooperative Groups for Pediatric Soft Tissue Sarcoma provides evidence that over time multimodal treatment including surgery and sarcoma-based chemotherapy has improved patient survival.
You have full text access to this OnlineOpen article
Selective upregulation of vascular endothelial growth factor receptors neuropilin-1 and -2 in human neuroblastoma (pages 258–263)Mitra Fakhari, Dieter Pullirsch, Dietmar Abraham, Kurosh Paya, Reinhold Hofbauer, Paul Holzfeind, Michael Hofmann and Seyedhossein Aharinejad
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10177
This study examined neuropilin-1 and –2 upregulation of vascular endothelial growth factor (VEGF) in human neuroblastoma, concluding that neuropilin might be a sensitive angiogenic measure of VEGF systems in neuroblastoma, particularly in its early stages.
You have full text access to this OnlineOpen article
Preradiation chemotherapy for pediatric patients with high-grade glioma (pages 264–271)Johannes E. A. Wolff, Astrid K. Gnekow, Rolf-Dieter Kortmann, Thorsten Pietsch, Christian Urban, Norbert Graf and Joachim Kühl
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10114
The authors investigated the feasibility and efficacy of intensive chemotherapy given prior to irradiation in pediatric patients with malignant glioma. The findings indicated that early, intensive chemotherapy increases survival rates in patients with completely resected malignant glioma.
Epidemiology
You have full text access to this OnlineOpen article
An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates (pages 272–281)William B. Grant
Article first published online: 28 DEC 2001 | DOI: 10.1002/cncr.10196
A multicountry ecologic study was conducted to determine dietary links to breast carcinoma mortality. It was found that the fraction of energy derived from animal products is the highest risk factor, and, conversely, that fraction of energy derived from vegetable products is the highest risk reduction factor, with latitude, an index for solar ultraviolet-B radiation playing an important role for developed Western countries, and alcohol (risk) and fish intake (risk reduction) playing minor roles.